The largest database of trusted experimental protocols

Amaxa nucleofector solution 5

Manufactured by Lonza
Sourced in Switzerland

The Amaxa Nucleofector solution V is a specialized buffer designed for use with the Amaxa Nucleofector system, a laboratory instrument for the transfection of cells. The solution provides the necessary components to facilitate the efficient introduction of nucleic acids, such as DNA or RNA, into a variety of cell types.

Automatically generated - may contain errors

5 protocols using amaxa nucleofector solution 5

1

CDKN2D Silencing in NB4 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The specific sequence used for CDKN2D silencing was selected from the WI siRNA Selection Program (http://sirna.wi.mit.edu/). A negative control sequence was used (AGC GUG UAG CUA GCA GAG G). A total of 2 × 106 NB4 cells were suspended in 100 μl Amaxa Nucleofector Solution V and mixed with 3 μg siRNA. Cells were then transfected by electroporation using Amaxa Nucleofector II device and program X-001. Six hours after transfection, cells were cultured for another 48 h in the absence or presence of 1 μM ATRA. The siRNA sequence targeting CDKN2D was as follows: forward: 5′- GUACCAGUCCAGUCCAUGAUU-3′ reverse: 5′- UCAUGGACUGGACUGGUACUU-3′.
+ Open protocol
+ Expand
2

Transfection of Sarcoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
GIST-T1, GIST430, RMS176, LMS04 and EWS502 cell monolayers were disaggregated with trypsin and resuspended in Amaxa Nucleofector solution V (Amaxa Biosystems) at a concentration of 1 × 106 cells per 100 μl. Nucleofection was performed using program T-030 on a Nucleofector II machine (Amaxa Biosystems). One microgram of pCR3.1-EGFP or pCR3.1-miniDMD plasmid was used for electroporation. Transfected cells were selected with G418 for 5 days before analyses.
+ Open protocol
+ Expand
3

Transfection of Sarcoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
GIST-T1, GIST430, RMS176, LMS04 and EWS502 cell monolayers were disaggregated with trypsin and resuspended in Amaxa Nucleofector solution V (Amaxa Biosystems) at a concentration of 1 × 106 cells per 100 μl. Nucleofection was performed using program T-030 on a Nucleofector II machine (Amaxa Biosystems). One microgram of pCR3.1-EGFP or pCR3.1-miniDMD plasmid was used for electroporation. Transfected cells were selected with G418 for 5 days before analyses.
+ Open protocol
+ Expand
4

Generation of Ku70 3A Mutant in Mouse Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse Ku70 cDNA was PCR amplified using the primers mKu70-Bam-ATG: 5′-GGCGGATCCATGTCAGAGTGGGAGTCCTAC-3′ and mKu70-Stop-Xho: 5′-GGCCTCGAGTCAGTTCTTCTCCAAGTGTCTG-3′ and then subcloned into the pCDNA3.1-YFP-F2 mammalian expression vector using BamHI and XhoI following standard protocols. PCR-directed mutagenesis using complimentary oligonucleotides was then used to generate mouse Ku70 3A. The following primers were used for the mutagenesis: mKu70-307A: 5′-GACTTTTAATGTAAACGCCGGCAGTCTACTCC-3′ and mKu70-314A/316A: 5′-CAGTCTACTCCTGCCTGCTGACGCCAAGCGGTCTCTGAC-3′ with the mKu70-307A primer set used first and then the mKu70-314A/316A primer set. To make Ku70−/− MEFs that stably express wild-type and Ku70 3A, 4 μg of linearized plasmid containing wild-type or Ku70 3A cDNA was transfected using Amaxa nucleofector solution V (Lonza) and program T-020. Cells stably expressing mKu70 were selected using 800 μg/ml hygromycin.
+ Open protocol
+ Expand
5

TRPML1 and PIKfyve Transfection Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
1×106 MCF10A–H2B–mCherry cells were nucleofected with TRPML1-eGFP with Amaxa Nucleofector Solution V (Lonza, Switzerland) and assayed 72h post-transfection. 1×106 HEK293 cells were plated in 6-well plates, transfected with 4ug PIKfyve-eGFP construct using Lipofectamine 2000 the next day and assayed 48h post-transfection. The pEGFPC1-TRPML1 construct was a kind gift from Dr. Shmuel Muallem, NIH, Bethesda, MD. PIKfyve-eGFP constructs were a kind gift from Dr. Frederic Meunier, University of Queensland, Australia and Dr. Assia Shisheva, Wayne State University, Mi.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!